Sanofi to help restructure EuroAPI
Submitted by:
Andrew Warmington
French-based CDMO EuroAPI has reached an agreement with Sanofi to finance the implementation of its
Consortium enters pandemic readiness
Submitted by:
Andrew Warmington
Following an expansion and qualification phase, the consortium formed by Wacker Chemie and CordenPharma in
Veranova to expand ADCs and high potency site
Submitted by:
Andrew Warmington
Veranova has initiated a “significant” expansion of its ADC and highly potent compound development and
Dottikon builds for small molecules
Submitted by:
Andrew Warmington
Swiss CDMO Dottikon Exclusive Synthesis (ES) is in the process of investing around CHF 700
CatSci buys Reach Separations
Submitted by:
Andrew Warmington
Drug development services supplier CatSci has acquired its UK compatriot Reach Separations. No financial details
Alchem facing EC cartel action
Submitted by:
Andrew Warmington
The European Commission has informed India’s Alchem International and its Hong Kong subsidiary of its
Solenis makes two buys
Submitted by:
Andrew Warmington
Solenis, which makes speciality chemicals for water-intensive industries, has made two acquisitions in the space
Solugen gets DOE loan for biofacility
Submitted by:
Andrew Warmington
Solugen has secured a conditional commitment for a $213.6 million loan guarantee from the US
Continuous metals monitor reveals environmental improvement opportunities
Submitted by:
Andrew Warmington
Graham Meller of Buttonwood Marketing shares some results from a recent trial of continuous
Siegfried to acquire Curia site
Submitted by:
Andrew Warmington
Swiss CDMO Siegfried has signed binding agreements with Curia Global for the acquisition of a